Strongyloidiasis

The protean parasitic infection

Jeffrey H. Schneider, Arvey I. Rogers

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

To turn well-known phrase regarding history, those who forget to diagnose strongyloidiasis will be condemned to rediscover it. The often protean manifestations of this disease cannot be emphasized enough. The parasite's unique life cycle enables it to live for decades in an unsuspecting host, presenting with symptomatic disease only occasionally. Making a definite diagnosis may be difficult and requires persistence. A good history should reveal whether a patient belongs to a high-risk group. The physician should strongly suspect the diagnosis when nonspecific when nonspecific cutaneous, pulmonary, and gastro-intestinal symptoms coexist. Unexplained enteric bacteremia or meningitis may be important clues to diagnosing disseminated disease, which carries a high morality rate. Therapy is available and advances are being made to make it more tolerable. Follow- up for eradication is laborious yet essential. In patients at high risk for disseminated disease, invasive procedures amy be warranted to prove eradication. Incomplete therapy puts the patient at further risk for significant complications in the future.

Original languageEnglish
Pages (from-to)177-192
Number of pages16
JournalPostgraduate Medicine
Volume102
Issue number3
StatePublished - Sep 1 1997

Fingerprint

Strongyloidiasis
Parasitic Diseases
History
Bacteremia
Life Cycle Stages
Meningitis
Parasites
Physicians
Lung
Skin
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Schneider, J. H., & Rogers, A. I. (1997). Strongyloidiasis: The protean parasitic infection. Postgraduate Medicine, 102(3), 177-192.

Strongyloidiasis : The protean parasitic infection. / Schneider, Jeffrey H.; Rogers, Arvey I.

In: Postgraduate Medicine, Vol. 102, No. 3, 01.09.1997, p. 177-192.

Research output: Contribution to journalArticle

Schneider, JH & Rogers, AI 1997, 'Strongyloidiasis: The protean parasitic infection', Postgraduate Medicine, vol. 102, no. 3, pp. 177-192.
Schneider JH, Rogers AI. Strongyloidiasis: The protean parasitic infection. Postgraduate Medicine. 1997 Sep 1;102(3):177-192.
Schneider, Jeffrey H. ; Rogers, Arvey I. / Strongyloidiasis : The protean parasitic infection. In: Postgraduate Medicine. 1997 ; Vol. 102, No. 3. pp. 177-192.
@article{8fe5cfdad5df496b820d698886f887d0,
title = "Strongyloidiasis: The protean parasitic infection",
abstract = "To turn well-known phrase regarding history, those who forget to diagnose strongyloidiasis will be condemned to rediscover it. The often protean manifestations of this disease cannot be emphasized enough. The parasite's unique life cycle enables it to live for decades in an unsuspecting host, presenting with symptomatic disease only occasionally. Making a definite diagnosis may be difficult and requires persistence. A good history should reveal whether a patient belongs to a high-risk group. The physician should strongly suspect the diagnosis when nonspecific when nonspecific cutaneous, pulmonary, and gastro-intestinal symptoms coexist. Unexplained enteric bacteremia or meningitis may be important clues to diagnosing disseminated disease, which carries a high morality rate. Therapy is available and advances are being made to make it more tolerable. Follow- up for eradication is laborious yet essential. In patients at high risk for disseminated disease, invasive procedures amy be warranted to prove eradication. Incomplete therapy puts the patient at further risk for significant complications in the future.",
author = "Schneider, {Jeffrey H.} and Rogers, {Arvey I.}",
year = "1997",
month = "9",
day = "1",
language = "English",
volume = "102",
pages = "177--192",
journal = "Postgraduate Medicine",
issn = "0032-5481",
publisher = "Medquest Communications LLC",
number = "3",

}

TY - JOUR

T1 - Strongyloidiasis

T2 - The protean parasitic infection

AU - Schneider, Jeffrey H.

AU - Rogers, Arvey I.

PY - 1997/9/1

Y1 - 1997/9/1

N2 - To turn well-known phrase regarding history, those who forget to diagnose strongyloidiasis will be condemned to rediscover it. The often protean manifestations of this disease cannot be emphasized enough. The parasite's unique life cycle enables it to live for decades in an unsuspecting host, presenting with symptomatic disease only occasionally. Making a definite diagnosis may be difficult and requires persistence. A good history should reveal whether a patient belongs to a high-risk group. The physician should strongly suspect the diagnosis when nonspecific when nonspecific cutaneous, pulmonary, and gastro-intestinal symptoms coexist. Unexplained enteric bacteremia or meningitis may be important clues to diagnosing disseminated disease, which carries a high morality rate. Therapy is available and advances are being made to make it more tolerable. Follow- up for eradication is laborious yet essential. In patients at high risk for disseminated disease, invasive procedures amy be warranted to prove eradication. Incomplete therapy puts the patient at further risk for significant complications in the future.

AB - To turn well-known phrase regarding history, those who forget to diagnose strongyloidiasis will be condemned to rediscover it. The often protean manifestations of this disease cannot be emphasized enough. The parasite's unique life cycle enables it to live for decades in an unsuspecting host, presenting with symptomatic disease only occasionally. Making a definite diagnosis may be difficult and requires persistence. A good history should reveal whether a patient belongs to a high-risk group. The physician should strongly suspect the diagnosis when nonspecific when nonspecific cutaneous, pulmonary, and gastro-intestinal symptoms coexist. Unexplained enteric bacteremia or meningitis may be important clues to diagnosing disseminated disease, which carries a high morality rate. Therapy is available and advances are being made to make it more tolerable. Follow- up for eradication is laborious yet essential. In patients at high risk for disseminated disease, invasive procedures amy be warranted to prove eradication. Incomplete therapy puts the patient at further risk for significant complications in the future.

UR - http://www.scopus.com/inward/record.url?scp=0030931492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030931492&partnerID=8YFLogxK

M3 - Article

VL - 102

SP - 177

EP - 192

JO - Postgraduate Medicine

JF - Postgraduate Medicine

SN - 0032-5481

IS - 3

ER -